Trials / Conditions / Lupus Erythematosus, Discoid

Lupus Erythematosus, Discoid

10 registered clinical trials studyying Lupus Erythematosus, Discoid.

Status	Trial	Sponsor	Phase
Active Not Recruiting	A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute NCT04857034	Bristol-Myers Squibb	Phase 2
Unknown	Efficacy of 595 nm Pulsed-dye Laser in Treatment of Discoid Lupus Erythematosus NCT03178188	Chulalongkorn University	Phase 2 / Phase 3
Completed	Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythemato NCT02656082	University of Leeds	Phase 2
Terminated	Autologous Polyclonal Tregs for Lupus NCT02428309	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Completed	A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy V NCT02034344	Janssen Research & Development, LLC	—
Completed	A Non-drug Study Profiling Cutaneous Lupus NCT01923415	Janssen Research & Development, LLC	—
Completed	Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Eryt NCT01597050	Rigel Pharmaceuticals	Phase 2
Completed	A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies NCT01858792	Human Genome Sciences Inc., a GSK Company	—
Completed	Phase Ib Study of SC Milatuzumab in SLE NCT01845740	Gilead Sciences	Phase 1
Withdrawn	Cutaneous Lupus Erythematosus and Elidel NCT00222183	University of Leipzig	N/A